Clincosm LogoSign in Get a demo

The Gastric Cancer Foundation: A Gastric Cancer Registry

Sponsor
Stanford University (Other)
Overall Status
Recruiting
CT.gov ID
NCT01514045
Collaborator
(none)
500
Enrollment
1
Location
176
Duration (Months)
2.8
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The Gastric Cancer Registry will combine data acquired directly from patients with gastric cancer; with a family history of gastric cancer in a first or second degree relative; or persons with a known germline mutation in their CDH1 (E-Cadherin) gene via an online questionnaire with genomic data obtained from saliva, blood and tissue samples. The purpose of this registry is to gain better understanding of the causes of gastric cancer, both environmental and genetic; whether certain genomic data can predict outcomes of treatment and survival.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Collect detailed clinical and epidemiological information on eligible patients via an online registry and a detailed patient questionnaire. Participants can opt in to contribute a blood or saliva sample and paraffin block samples from a previous gastric surgery.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    500 participants
    Observational Model:
    Ecologic or Community
    Time Perspective:
    Cross-Sectional
    Official Title:
    The Gastric Cancer Foundation: A Gastric Cancer Registry
    Study Start Date :
    Apr 1, 2011
    Anticipated Primary Completion Date :
    Dec 1, 2022
    Anticipated Study Completion Date :
    Dec 1, 2025

    Outcome Measures

    Primary Outcome Measures

    1. Collect detailed clinical and epidemiological information on patients with gastric cancer; with a family history of gastric cancer in a first or second degree relative; or persons with a known germline mutation in their CDH1 (E-Cadherin) gene [1 day]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    1. Patients are eligible if they have a histologically proven gastric tumor including gastroesophageal tumors; OR they have a family history of gastric cancer in a first or second degree relative; OR persons with a known germline mutation in their CDH1 (E-Cadherin) gene.

    2. 18 years of age or older

    3. Adequate English proficiency to complete online consent and questionnaire. Spanish-language proficiency as an alternative to English-language proficiency.

    Exclusion Criteria:

    1. Under 18 years of age

    2. No history of gastric cancer or gastric cancer in a family member or a known germline mutation in their CDH1 gene.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Stanford University, School of Medicine Stanford California United States 94305

    Sponsors and Collaborators

    • Stanford University

    Investigators

    • Principal Investigator: Hanlee P Ji, MD, Stanford University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Stanford University
    ClinicalTrials.gov Identifier:
    NCT01514045
    Other Study ID Numbers:
    • IRB-20285
    • SU-01172012-8987
    • GI0005
    First Posted:
    Jan 20, 2012
    Last Update Posted:
    Sep 10, 2021
    Last Verified:
    Sep 1, 2021
    Keywords provided by Stanford University
    Quality of Life
    Additional relevant MeSH terms:
    Stomach Neoplasms

    Study Results

    No Results Posted as of Sep 10, 2021